EMA/PE/0000252572 - paediatric investigation plan

ferumoxtran

Key facts

• Active substance:
  ferumoxtran
• Therapeutic area:
  Neoplasms benign, malignant and unspecified (incl cysts and polyps)
• Decision number:
  EMA/PE/0000252572
• PIP number:
  EMA/PE/0000252572
• Pharmaceutical form(s):
  All pharmaceutical forms
• Condition(s) / indication(s):
  Diagnosis of primary tumour spread in prostate cancer
• Route(s) of administration:
  All routes of administration
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  10/07/2025
• Compliance check done:
  Nei

Decision

EMA/PE/0000252572 : EMA decision of 10 July 2025 on the granting of a product specific waiver for ferumoxtran

Adopted Reference Number: EMADOC-1700519818-2259159